Form 8-K

8-K — COLGATE PALMOLIVE CO

Accession: 0000021665-26-000041

Filed: 2026-07-31

Period: 2026-07-31

CIK: 0000021665

SIC: 2844 (PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS)

Item: Results of Operations and Financial Condition

Item: Financial Statements and Exhibits

Documents

8-K — cl-20260731.htm (Primary)

EX-99 (q22026pressreleasetables.htm)

GRAPHIC (image.jpg)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K

8-K (Primary)

Filename: cl-20260731.htm · Sequence: 1

cl-20260731

0000021665False00000216652026-07-312026-07-310000021665us-gaap:CommonStockMember2026-07-312026-07-310000021665cl:A0.300NotesDue2029Member2026-07-312026-07-310000021665cl:A1.375NotesDue2034Member2026-07-312026-07-310000021665cl:A3.250NotesDue2035Member2026-07-312026-07-310000021665cl:A0.875NotesDue2039Member2026-07-312026-07-31

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

________________

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) July 31, 2026

COLGATE-PALMOLIVE COMPANY

(Exact name of registrant as specified in its charter)

Delaware

1-644

13-1815595

(State or Other Jurisdiction of Incorporation)

(Commission File Number)

(IRS Employer Identification No.)

300 Park Avenue,

New York, NY 10022

(Address of Principal Executive Offices)

(Zip Code)

Registrant’s telephone number, including area code (212) 310-2000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Securities 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange

on which registered

Common Stock, $1.00 par value

New York Stock Exchange

0.300% Notes due 2029

CL29

New York Stock Exchange

1.375% Notes due 2034

CL34

New York Stock Exchange

3.250% Notes due 2035

CL35

New York Stock Exchange

0.875% Notes due 2039

CL39

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02. Results of Operations and Financial Condition.

On July 31, 2026, Colgate-Palmolive Company (the “Company”) issued a press release announcing its earnings for the quarter ended June 30, 2026. This press release is attached as Exhibit 99 and is incorporated herein by reference.

The information in Item 2.02 of this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in Item 2.02 of this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits. The following exhibits are filed with this document:

Exhibit Number

Description

Press release, dated July 31, 2026, issued by Colgate-Palmolive Company

104

Cover Page Interactive Data File (embedded within the Inline eXtensible Business Reporting Language (Inline XBRL) document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

COLGATE-PALMOLIVE COMPANY

Date: July 31, 2026

By:

/s/ Stanley J. Sutula III

Name: Stanley J. Sutula III

Title: Chief Financial Officer

EX-99

Filename: q22026pressreleasetables.htm · Sequence: 2

Document

Exhibit 99

Colgate Announces 2nd Quarter 2026 Results

•Net sales increased 4.9%; Organic sales* increased 2.4%, including a 0.4% negative impact from lower private label pet food sales

•GAAP EPS decreased 5% to $0.86; Base Business EPS* increased 8% to $0.99

•GAAP Gross profit margin and Base Business Gross profit margin* increased 140 basis points to 61.5%

•Net cash provided by operations was $1,742 million for the first six months of 2026

•The Company’s leadership in toothpaste continued with its global market share at 41.3% year to date

•The Company’s leadership in manual toothbrushes continued with its global market share at 32.7% year to date

•The Company maintained its sales and GAAP earnings per share guidance and updated its gross profit margin and Base Business earnings per share guidance for full year 2026

Second Quarter Total Company Results (GAAP)

($ in millions except per share amounts) 2026 2025 Change

Net Sales $5,361 $5,110 +4.9 %

EPS (diluted) $0.86 $0.91 -5 %

Second Quarter Total Company Results (Base Business - Non-GAAP)*

2026 2025 Change

Organic Sales Growth +2.4 %

Base Business EPS (diluted) $0.99 $0.92 +8 %

*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 6 - Geographic Sales Analysis Percentage Changes” and “Table 8 - Non-GAAP Reconciliations” included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures.

New York, New York, July 31, 2026…Colgate-Palmolive Company (NYSE:CL) today reported results for second quarter 2026. Noel Wallace, Chairman, President and Chief Executive Officer, commented on the Base Business second quarter results, “Our growth momentum continued in the second quarter, as we delivered strong broad-based top- and bottom-line results, despite a difficult operating environment. Net sales and organic sales grew in three of four categories and in four of five divisions with worldwide organic volume growth improving sequentially for the third consecutive quarter. Gross profit margin, operating profit, operating profit margin, net income, earnings per share and free cash flow all increased year over year.

“We delivered these strong results while continuing to invest in the long-term health of our business with a 15% increase in advertising this quarter. Strong levels of investment will continue in the back half of the year as we execute against our 2030 strategy with a focus on premium, science-led innovation and omni-channel demand generation to drive brand health and category growth.

“While we expect the volatile market conditions to continue in the balance of 2026, we are confident that the strength of our global portfolio and clear business strategy should enable us to deliver consistent, compounded earnings per share growth and drive long-term shareholder value.”

Full Year 2026 Guidance

Based on current spot rates:

•The Company still expects net sales to be up 2% to 6%, including a low-single-digit positive impact from foreign exchange.

•The Company still expects organic sales growth to be 1% to 4%. This includes the impact from our exit from the private label pet food business.

•On a GAAP basis, the Company now expects gross profit margin to be roughly flat (versus down previously) and still expects advertising to be up on both a dollar basis and as a percentage of net sales and double-digit earnings per share growth.

•On a non-GAAP (Base Business) basis, the Company now expects gross profit margin to be roughly flat (versus down previously) and still expects advertising to be up on both a dollar basis and as a percentage of net sales; it also now expects mid-single-digit earnings per share growth (versus low- to mid-single-digit growth previously).

Divisional Performance

See attached "Table 6 - Geographic Sales Analysis Percentage Changes" and "Table 5 - Segment Information" for additional information on net sales and operating profit by division.

Second Quarter Sales Growth By Division

(% change 2Q 2026 vs. 2Q 2025 except % of Total Company Sales)

% of Total Company Sales Net

Sales Organic

Sales* As Reported

Volume** Organic Volume Pricing FX

North America(1)

17% -3.0% -3.0% -3.9% -3.9% +0.9% —%

Latin America 26% +13.7% +5.3% +2.6% +2.6% +2.8% +8.4%

Europe, Middle East & Africa(1)

21% +3.5% +2.0% +3.2% +3.2% -1.2% +1.6%

Asia Pacific(1)

14% +4.9% +5.2% +4.1% +4.1% +1.1% -0.3%

Hill’s Pet Nutrition

22% +3.4% +2.1% -1.2% -1.8% +3.9% +0.6%

Total Company 100% +4.9% +2.4% +0.9% +0.8% +1.6% +2.4%

Table may not sum due to rounding.

(1) The Company has recast its historical geographic segment information to conform to the reporting structure effective for the quarter ended March 31, 2026. Recast historical geographic segment information can be found on the Company's website.

*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 6 - Geographic Sales Analysis Percentage Changes” included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures.

**The impact of the acquisition of the Prime100 pet food business on as reported volume was 0.6% and 0.1% for Hill's Pet Nutrition and Total Company, respectively.

Second Quarter Operating Profit By Division

($ in millions)

2Q 2026

% Change vs 2Q 2025

% to Net Sales

Change in basis points vs 2Q 2025

% to Net Sales

North America(1)

$192 3% 21.6% +120

Latin America $418 14% 30.4% —

Europe, Middle East & Africa(1)

$263 9% 23.4% +120

Asia Pacific(1)

$209 3% 26.7% -40

Hill’s Pet Nutrition

$269 2% 22.5% -40

Total Company, As Reported $1,016 -6% 19.0% -210

Total Company, Base Business* $1,145 5% 21.4% +10

(1) The Company has recast its historical geographic segment information to conform to the reporting structure effective for the quarter ended March 31, 2026.

*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 8 - Non-GAAP Reconciliations” included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures.

Prepared Materials and Webcast Information

At approximately 7:00 a.m. ET today, the Company will post its prepared materials regarding second quarter results to the Investor Center section of its website at https://investor.colgatepalmolive.com/events-and-presentations.

At 8:30 a.m. ET today, the Company will host a conference call regarding second quarter results. To access this call as a webcast, please go to Colgate-Palmolive’s website at www.colgatepalmolive.com.

About Colgate-Palmolive

Colgate-Palmolive Company is a caring, innovative growth company that is reimagining a healthier future for all people, their pets and our planet. Focused on Oral Care, Personal Care, Home Care and Pet Nutrition, we sell our products in more than 200 countries and territories under brands such as Colgate, Palmolive, Ajax, Axion, Darlie, elmex, EltaMD, Fabuloso, Filorga, hello, Hill’s Prescription Diet, Hill’s Science Diet, Irish Spring, Lady Speed Stick, meridol, PCA SKIN, Prime100, Protex, Sanex, Softsoap, Sorriso, Soupline, Speed Stick, Suavitel and Tom’s of Maine. We are recognized for our leadership and innovation in promoting sustainability and community wellbeing, including our achievements in decreasing plastic waste and promoting recyclability, saving water and improving children’s oral health through our Colgate Bright Smiles, Bright Futures program, which has reached approximately two billion children and their families since 1991. For more information about Colgate-Palmolive and how we make more smiles, visit www.colgatepalmolive.com. CL-E

Market Share Information

Management uses market share information as a key indicator to monitor business health and performance. References to market share in this press release are based on a combination of consumption and market share data provided by third-party vendors, primarily Nielsen, and internal estimates. Except as otherwise noted, all market share references represent the percentage of the dollar value of sales of our products, relative to all product sales in the category in the countries in which the Company competes and purchases data (excluding Venezuela from all periods).

Market share data is subject to limitations on the availability of up-to-date information. In particular, market share data is currently not generally available for certain retail channels, such as eCommerce and certain club retailers and discounters. The Company measures year-to-date market shares from January 1 of the relevant year through the most recent period for which market share data is available, which typically reflects a lag time of one or two months. The Company believes that the third-party vendors it uses to provide data are reliable, but it has not verified the accuracy or completeness of the data or any assumptions underlying the data. In addition, market share information reported by the Company may be different from market share information reported by other companies due to differences in category definitions, the use of data from different countries, internal estimates and other factors.

Cautionary Statement on Forward-Looking Statements

This press release and the related prepared materials and webcast may contain forward-looking statements (as that term is defined in the U.S. Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission (SEC) in its rules, regulations and releases) that set forth anticipated results based on management’s current plans and assumptions. Such statements may relate, for example, to sales or volume growth, net selling price increases, organic sales growth, profit or profit margin levels, earnings per share levels, financial goals, category growth rates, the impact of foreign exchange, the impact of developments in global trade relations and tariffs, the impact of geopolitical events and tensions, wars and military conflicts, such as in Ukraine and the Middle East, cost reduction plans (including the Strategic Growth and Productivity Program), tax rates, interest rates, new product introductions, digital capabilities, commercial investment levels, acquisitions, divestitures, share repurchases or legal or tax proceedings, among other matters. These statements are made on the basis of the Company’s views and assumptions as of July 31, 2026. The Company undertakes no obligation to update these statements whether as a result of new information, future events or otherwise, except as required by law or by the rules and regulations of the SEC. Moreover, the Company does not, nor does any other person, assume responsibility for the accuracy and completeness of these statements. The Company cautions investors that any such forward-looking statements are not guarantees of future performance and that actual events or results may differ materially from those statements. For more information about factors that could impact the Company’s business and cause actual results to differ materially from forward-looking statements, investors should refer to the Company’s filings with the SEC (including, but not limited to, the information set forth under the captions “Risk Factors” and “Cautionary Statement on Forward-Looking Statements” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025 and subsequent filings with the SEC). Copies of these filings may be obtained upon request from the Company’s Investor Relations Department or on the Company’s website at www.colgatepalmolive.com.

Non-GAAP Financial Measures

The following provides definitions and other information regarding the non-GAAP financial measures used in this press release and the related prepared materials and webcast, which may not be the same as or comparable to similar measures presented by other companies:

•Base Business: Base Business refers to non-GAAP measures of operating results that exclude certain items. Base Business operating results exclude, as applicable, charges related to the Strategic Growth and Productivity Program and the ERISA litigation matter and acquisition-related costs.

•Organic sales growth: Net sales growth excluding the impact of foreign exchange, acquisitions and divestments.

•Free cash flow before dividends: Net cash provided by operations less Capital expenditures.

This press release and the related prepared materials and webcast discuss Net sales growth (GAAP) and Organic sales growth (non-GAAP). Management believes the organic sales growth measure provides investors and analysts with useful supplemental information regarding the Company’s underlying sales trends by presenting sales growth excluding the external factor of foreign exchange as well as the impact from acquisitions and divestments. See “Geographic Sales Analysis Percentage Changes” for the three and six months ended June 30, 2026 versus 2025 included with this release for a comparison of Organic sales growth to Net sales growth in accordance with GAAP.

Gross profit, Selling, general and administrative expenses, Selling, general and administrative expenses as a percentage of Net sales, Other (income) expense, net, Operating profit, Operating profit margin, Non-service related postretirement costs, Effective income tax rate, Net income attributable to Colgate-Palmolive Company and Diluted earnings per common share are disclosed on both an as reported (GAAP) and Base Business (non-GAAP) basis. These non-GAAP financial measures exclude items that, either by their nature or amount, management would not expect to occur as part of the Company’s normal business on a regular basis, such as restructuring charges, charges for certain litigation and tax matters, acquisition-related costs, gains and losses from certain divestitures and certain other unusual, non-recurring items. Investors and analysts use these financial measures in assessing the Company’s business performance, and management believes that presenting these financial measures on a non-GAAP basis provides them with useful supplemental information to enhance their understanding of the Company’s underlying business performance and trends. These non-GAAP financial measures also enhance the ability to compare period-to-period financial results. See “Non-GAAP Reconciliations” for the three and six months ended June 30, 2026 and 2025 included with this release for a reconciliation of these financial measures to the related GAAP measures.

The Company uses these financial measures internally in its budgeting process, to evaluate segment and overall operating performance and as factors in determining compensation. While the Company believes that these financial measures are useful in evaluating the Company’s underlying business performance and trends, this information should be considered as supplemental in nature and is not meant to be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP.

As management uses free cash flow before dividends to evaluate the Company’s ability to satisfy current and future obligations, pay dividends, fund future business opportunities and repurchase stock, the Company believes that it provides useful information to investors. Free cash flow before dividends is not a measure of cash available for discretionary expenditures since the Company has certain non-discretionary obligations such as debt service that are not deducted from the measure. See “Condensed Consolidated Statements of Cash Flows” for the six months ended June 30, 2026 and 2025 for a comparison of free cash flow before dividends to Net cash provided by operations as reported in accordance with GAAP.

(See attached tables for second quarter results.)

Contacts

Investor Relations: investor_relations@colpal.com

Communications: colgate_palmolive_media_inquiry@colpal.com

Table 1

Colgate-Palmolive Company

Condensed Consolidated Statements of Income

For the Three Months Ended June 30, 2026 and 2025

(Dollars in Millions Except Per Share Amounts) (Unaudited)

2026 2025

Net sales $ 5,361 $ 5,110

Cost of sales 2,065 2,041

Gross profit 3,296 3,069

Gross profit margin 61.5 % 60.1 %

Selling, general and administrative expenses 2,130 1,963

Other (income) expense, net 150 26

Operating profit 1,016 1,080

Operating profit margin 19.0 % 21.1 %

Non-service related postretirement costs 21 23

Interest expense 62 71

Interest income 17 21

Income before income taxes 950 1,007

Provision for income taxes 231 234

Effective tax rate 24.3 % 23.2 %

Net income including noncontrolling interests 719 773

Less: Net income attributable to noncontrolling interests 26 30

Net income attributable to Colgate-Palmolive Company $ 693 $ 743

Earnings per common share

Basic $ 0.87 $ 0.92

Diluted $ 0.86 $ 0.91

Supplemental Income Statement Information

Average common shares outstanding

Basic 799.4 810.2

Diluted 801.8 813.3

Advertising $ 777 $ 678

Table 2

Colgate-Palmolive Company

Condensed Consolidated Statements of Income

For the Six Months Ended June 30, 2026 and 2025

(Dollars in Millions Except Per Share Amounts) (Unaudited)

2026 2025

Net sales $ 10,686 $ 10,021

Cost of sales 4,164 3,965

Gross profit 6,522 6,056

Gross profit margin 61.0 % 60.4 %

Selling, general and administrative expenses 4,206 3,861

Other (income) expense, net 336 39

Operating profit 1,980 2,156

Operating profit margin 18.5 % 21.5 %

Non-service related postretirement costs 47 95

Interest expense 124 137

Interest income 33 35

Income before income taxes 1,842 1,959

Provision for income taxes 441 460

Effective tax rate 23.9 % 23.5 %

Net income including noncontrolling interests 1,401 1,499

Less: Net income attributable to noncontrolling interests 62 66

Net income attributable to Colgate-Palmolive Company $ 1,339 $ 1,433

Earnings per common share

Basic(1)

$ 1.67 $ 1.77

Diluted(1)

$ 1.67 $ 1.76

Supplemental Income Statement Information

Average common shares outstanding

Basic 800.8 811.2

Diluted 803.4 814.2

Advertising $ 1,511 $ 1,346

Note:

(1) Basic and diluted earnings per share are computed independently for each quarter and any year-to-date period presented. As a result of changes in shares outstanding during the year and rounding, the sum of the quarters' earnings per share may not equal the earnings per share for any year-to-date period.

Table 3

Colgate-Palmolive Company

Condensed Consolidated Balance Sheets

As of June 30, 2026, December 31, 2025 and June 30, 2025

(Dollars in Millions) (Unaudited)

June 30, December 31, June 30,

2026 2025 2025

Cash and cash equivalents $ 1,370 $ 1,288 $ 1,215

Receivables, net 1,962 1,675 1,773

Inventories 2,181 2,032 2,120

Other current assets 795 714 888

Property, plant and equipment, net 4,639 4,660 4,529

Goodwill 3,100 3,122 3,696

Other intangible assets, net 1,495 1,536 1,904

Other assets 1,248 1,303 1,345

Total assets $ 16,790 $ 16,330 $ 17,470

Total debt $ 7,857 $ 7,988 $ 8,758

Other current liabilities 6,114 5,736 5,161

Other non-current liabilities 2,253 2,241 2,499

Total liabilities 16,224 15,965 16,418

Total Colgate-Palmolive Company shareholders’ equity 236 54 702

Noncontrolling interests 330 311 350

Total liabilities and equity $ 16,790 $ 16,330 $ 17,470

Supplemental Balance Sheet Information

Debt less cash, cash equivalents and marketable securities(1)

$ 6,404 $ 6,593 $ 7,346

Working capital % of sales (5.9) % (7.0) % (2.9) %

Note:

(1) Marketable securities of $83, $107 and $197 as of June 30, 2026, December 31, 2025 and June 30, 2025, respectively, are included in Other current assets.

Table 4

Colgate-Palmolive Company

Condensed Consolidated Statements of Cash Flows

For the Six Months Ended June 30, 2026 and 2025

(Dollars in Millions) (Unaudited)

2026 2025

Operating Activities

Net income including noncontrolling interests $ 1,401 $ 1,499

Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations:

Depreciation and amortization 311 299

ERISA litigation matter — 65

Restructuring and termination benefits, net of cash 232 (13)

Stock-based compensation expense 78 55

Deferred income taxes (15) (17)

Cash effects of changes in:

Receivables (274) (152)

Inventories (110) 3

Accounts payable and other working capital 124 (248)

Other non-current assets 47 31

Other non-current liabilities (52) (38)

Net cash provided by (used in) operations 1,742 1,484

Investing Activities

Capital expenditures (266) (232)

Purchases of marketable securities and investments (124) (384)

Proceeds from sale of marketable securities and investments 150 350

Payment for acquisition, net of cash acquired — (293)

Other investing activities (4) (1)

Net cash provided by (used in) investing activities (244) (560)

Financing Activities

Short-term borrowing (repayment) less than 90 days, net 1,053 (30)

Principal payments on debt (1,086) (139)

Proceeds from issuance of debt — 497

Dividends paid (879) (880)

Purchases of treasury shares (597) (516)

Proceeds from exercise of stock options 138 65

Other financing activities (43) 136

Net cash provided by (used in) financing activities (1,414) (867)

Effect of exchange rate changes on Cash and cash equivalents (2) 62

Net increase (decrease) in Cash and cash equivalents 82 119

Cash and cash equivalents at beginning of the period 1,288 1,096

Cash and cash equivalents at end of the period $ 1,370 $ 1,215

Supplemental Cash Flow Information

Free cash flow before dividends (Net cash provided by operations less Capital expenditures)

Net cash provided by operations $ 1,742 $ 1,484

Less: Capital expenditures (266) (232)

Free cash flow before dividends $ 1,476 $ 1,252

Income taxes paid $ 459 $ 530

Interest paid $ 127 $ 137

Table 5

Colgate-Palmolive Company

Segment Information

For the Three and Six Months Ended June 30, 2026 and 2025

(Dollars in Millions) (Unaudited)

Three Months Ended June 30, Six Months Ended June 30,

2026 2025 2026 2025

Net Sales

Oral, Personal and Home Care

North America(1)

$ 891 $ 919 $ 1,779 $ 1,823

Latin America 1,372 1,207 2,685 2,350

Europe, Middle East & Africa(1)

1,121 1,083 2,247 2,089

Asia Pacific(1)

782 746 1,586 1,484

Total Oral, Personal and Home Care 4,166 3,954 8,297 7,746

Hill's Pet Nutrition 1,195 1,157 2,389 2,275

Total Net Sales $ 5,361 $ 5,110 $ 10,686 $ 10,021

Three Months Ended June 30, Six Months Ended June 30,

2026 2025 2026 2025

Operating Profit

Oral, Personal and Home Care

North America(1)

$ 192 $ 187 $ 333 $ 384

Latin America 418 367 819 715

Europe, Middle East & Africa(1)

263 241 529 463

Asia Pacific(1)

209 202 431 407

Total Oral, Personal and Home Care 1,082 997 2,112 1,968

Hill's Pet Nutrition 269 264 549 523

Corporate(2)

(335) (181) (681) (334)

Total Operating Profit $ 1,016 $ 1,080 $ 1,980 $ 2,156

Tables may not sum due to rounding.

Notes:

(1) The Company has recast its historical geographic segment information to conform to the reporting structure effective for the quarter ended March 31, 2026.

(2) Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs, restructuring and related implementation charges and gains and losses on sales of non-core product lines and assets.

Corporate Operating profit (loss) for the three and six months ended June 30, 2026 included charges resulting from the Strategic Growth and Productivity Program of $129 and $300, respectively.

Corporate Operating profit (loss) for the three months ended June 30, 2025 included acquisition-related costs of $9.

Corporate Operating profit (loss) for the six months ended June 30, 2025 included charges resulting from the ERISA litigation matter of $15 and acquisition-related costs of $9.

Table 6

Colgate-Palmolive Company

Geographic Sales Analysis Percentage Changes

For the Three Months Ended June 30, 2026 vs. 2025

(Unaudited)

COMPONENTS OF SALES CHANGE

Pricing

Coupons

Sales Consumer &

Change Organic As Reported Organic Trade Foreign

Region As Reported Sales Change

Volume(1)

Volume Incentives Exchange

Total Company 4.9 % 2.4 % 0.9 % 0.8 % 1.6 % 2.4 %

North America(2)

(3.0) % (3.0) % (3.9) % (3.9) % 0.9 % — %

Latin America 13.7 % 5.3 % 2.6 % 2.6 % 2.8 % 8.4 %

Europe, Middle East & Africa(2)

3.5 % 2.0 % 3.2 % 3.2 % (1.2) % 1.6 %

Asia Pacific(2)

4.9 % 5.2 % 4.1 % 4.1 % 1.1 % (0.3) %

Total CP Products 5.4 % 2.4 % 1.5 % 1.5 % 0.9 % 2.9 %

Hill’s Pet Nutrition 3.4 % 2.1 % (1.2) % (1.8) % 3.9 % 0.6 %

Emerging Markets(3)

9.2 % 4.8 % 2.8 % 2.8 % 1.9 % 4.4 %

Developed Markets

1.6 % 0.5 % (0.6) % (0.9) % 1.3 % 0.9 %

Table may not sum due to rounding.

Notes:

(1) The impact of the acquisition of the Prime100 pet food business on as reported volume was 0.1%, 0.6% and 0.3% for Total Company, Hill's Pet Nutrition and Developed Markets, respectively.

(2) The Company has recast its historical geographic segment information to conform to the reporting structure effective for the quarter ended March 31, 2026.

(3) Emerging Markets include Latin America, Asia (excluding Japan), Africa, the Middle East and Eastern and Central Europe.

Table 7

Colgate-Palmolive Company

Geographic Sales Analysis Percentage Changes

For the Six Months Ended June 30, 2026 vs. 2025

(Unaudited)

COMPONENTS OF SALES CHANGE

Pricing

Coupons

Sales Consumer &

Change Organic As Reported Organic Trade Foreign

Region As Reported Sales Change

Volume(1)

Volume Incentives Exchange

Total Company 6.6 % 2.6 % 1.0 % 0.7 % 1.9 % 3.8 %

North America(2)

(2.4) % (2.6) % (3.6) % (3.6) % 0.9 % 0.2 %

Latin America 14.3 % 5.3 % 2.3 % 2.3 % 3.1 % 8.9 %

Europe, Middle East & Africa(2)

7.5 % 2.7 % 2.7 % 2.7 % — % 4.9 %

Asia Pacific(2)

6.9 % 5.4 % 4.3 % 4.3 % 1.1 % 1.5 %

Total CP Products 7.1 % 2.8 % 1.4 % 1.4 % 1.3 % 4.4 %

Hill’s Pet Nutrition 5.0 % 2.1 % (0.5) % (1.8) % 3.9 % 1.7 %

Emerging Markets(3)

11.0 % 5.5 % 3.2 % 3.2 % 2.3 % 5.5 %

Developed Markets 3.2 % 0.4 % (0.7) % (1.3) % 1.6 % 2.3 %

Table may not sum due to rounding.

Notes:

(1) The impact of the acquisition of the Prime100 pet food business on as reported volume was 0.3%, 1.3% and 0.6% for Total Company, Hill's Pet Nutrition and Developed Markets, respectively.

(2) The Company has recast its historical geographic segment information to conform to the reporting structure effective for the quarter ended March 31, 2026.

(3) Emerging Markets include Latin America, Asia (excluding Japan), Africa, the Middle East and Eastern and Central Europe.

Table 8

Colgate-Palmolive Company

Non-GAAP Reconciliations

For the Three Months Ended June 30, 2026 and 2025

(Dollars in Millions Except Per Share Amounts) (Unaudited)

Gross Profit 2026 2025

Gross profit, GAAP $ 3,296 $ 3,069

Strategic Growth and Productivity Program 2 —

Gross profit, non-GAAP $ 3,297 $ 3,069

Selling, General and Administrative Expenses 2026 2025

Selling, general and administrative expenses, GAAP $ 2,130 $ 1,963

Strategic Growth and Productivity Program (7) —

Selling, general and administrative expenses, non-GAAP $ 2,122 $ 1,963

Basis Point

Selling, General and Administrative Expenses as a Percentage of Net Sales 2026 2025 Change

Selling, general and administrative expenses as a percentage of Net sales, GAAP 39.7 % 38.4 % 130

Strategic Growth and Productivity Program (0.1) % — %

Selling, general and administrative expenses as a percentage of Net sales, non-GAAP 39.6 % 38.4 % 120

Other (Income) Expense, Net 2026 2025

Other (income) expense, net, GAAP $ 150 $ 26

Strategic Growth and Productivity Program (120) —

Acquisition-related costs — (9)

Other (income) expense, net, non-GAAP $ 30 $ 17

Operating Profit 2026 2025 % Change

Operating profit, GAAP $ 1,016 $ 1,080 (6) %

Strategic Growth and Productivity Program 129 —

Acquisition-related costs — 9

Operating profit, non-GAAP $ 1,145 $ 1,089 5 %

Basis Point

Operating Profit Margin 2026 2025 Change

Operating profit margin, GAAP 19.0 % 21.1 % (210)

Strategic Growth and Productivity Program 2.4 % — %

Acquisition-related costs — % 0.2 %

Operating profit margin, non-GAAP 21.4 % 21.3 % 10

Note: The impact of non-GAAP adjustments may not necessarily equal the difference between “GAAP” and “non-GAAP” as a result of rounding.

Table 8

Continued

Colgate-Palmolive Company

Non-GAAP Reconciliations

For the Three Months Ended June 30, 2026 and 2025

(Dollars in Millions Except Per Share Amounts) (Unaudited)

2026

Income Before

Income Taxes

Provision For Income Taxes(1)

Net Income

Including

Noncontrolling

Interests Less: Income Attributable to Noncontrolling Interests Net Income

Attributable To

Colgate-Palmolive

Company

Effective Income

Tax Rate(2)

Diluted Earnings

Per Share

As Reported GAAP $ 950 $ 231 $ 719 $ 26 $ 693 24.3 % $ 0.86

Strategic Growth and Productivity Program 129 24 105 1 104 (0.7) % 0.13

Non-GAAP $ 1,079 $ 255 $ 824 $ 27 $ 797 23.6 % $ 0.99

2025

Income Before

Income Taxes

Provision For Income Taxes(1)

Net Income

Including

Noncontrolling

Interests Less: Income Attributable to Noncontrolling Interests Net Income

Attributable To

Colgate-Palmolive

Company

Effective Income

Tax Rate(2)

Diluted Earnings

Per Share

As Reported GAAP $ 1,007 $ 234 $ 773 $ 30 $ 743 23.2 % $ 0.91

Acquisition-related costs 9 2 7 — 7 — % 0.01

Non-GAAP $ 1,016 $ 236 $ 780 $ 30 $ 750 23.2 % $ 0.92

The impact of non-GAAP adjustments may not necessarily equal the difference between “GAAP” and “non-GAAP” as a result of rounding.

Notes:

(1) The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.

(2) The impact of non-GAAP items on the Company’s effective tax rate represents the difference in the effective tax rate calculated with and without the non-GAAP adjustment on Income before income taxes and Provision for income taxes.

Table 9

Colgate-Palmolive Company

Non-GAAP Reconciliations

For the Six Months Ended June 30, 2026 and 2025

(Dollars in Millions Except Per Share Amounts) (Unaudited)

Gross Profit 2026 2025

Gross profit, GAAP $ 6,522 $ 6,056

Strategic Growth and Productivity Program 2 —

Gross profit, non-GAAP $ 6,524 $ 6,056

Selling, General and Administrative Expenses 2026 2025

Selling, general and administrative expenses, GAAP $ 4,206 $ 3,861

Strategic Growth and Productivity Program (13) —

ERISA litigation matter — (15)

Selling, general and administrative expenses, non-GAAP $ 4,194 $ 3,845

Basis Point

Selling, General and Administrative Expenses as a Percentage of Net Sales 2026 2025 Change

Selling, general and administrative expenses as a percentage of Net sales, GAAP 39.4 % 38.5 % 90

Strategic Growth and Productivity Program (0.2) % — %

ERISA litigation matter — % (0.1) %

Selling, general and administrative expenses as a percentage of Net sales, non-GAAP 39.2 % 38.4 % 80

Other (Income) Expense, Net 2026 2025

Other (income) expense, net, GAAP $ 336 $ 39

Strategic Growth and Productivity Program (285) —

Acquisition-related costs — (9)

Other (income) expense, net, non-GAAP $ 51 $ 30

Operating Profit 2026 2025 % Change

Operating profit, GAAP

$ 1,980 $ 2,156 (8) %

Strategic Growth and Productivity Program 300 —

ERISA litigation matter — 15

Acquisition-related costs — 9

Operating profit, non-GAAP

$ 2,279 $ 2,181 5 %

Basis Point

Operating Profit Margin 2026 2025 Change

Operating profit margin, GAAP 18.5 % 21.5 % (300)

Strategic Growth and Productivity Program 2.8 % — %

ERISA litigation matter — % 0.2 %

Acquisition-related costs — % 0.1 %

Operating profit margin, non-GAAP 21.3 % 21.8 % (50)

Non-Service Related Postretirement Costs 2026 2025

Non-service related postretirement costs, GAAP $ 47 $ 95

Strategic Growth and Productivity Program (5) —

ERISA litigation matter — (50)

Non-service related postretirement costs, non-GAAP $ 41 $ 45

Note: The impact of non-GAAP adjustments may not necessarily equal the difference between “GAAP” and “non-GAAP” as a result of rounding.

Table 9

Continued

Colgate-Palmolive Company

Non-GAAP Reconciliations

For the Six Months Ended June 30, 2026 and 2025

(Dollars in Millions Except Per Share Amounts) (Unaudited)

2026

Income Before

Income Taxes

Provision For Income Taxes(1)

Net Income

Including

Noncontrolling

Interests Less: Income Attributable to Noncontrolling Interests Net Income

Attributable To

Colgate-Palmolive

Company

Effective Income

Tax Rate(2)

Diluted Earnings

Per Share

As Reported GAAP $ 1,842 $ 441 $ 1,401 $ 62 $ 1,339 23.9 % $ 1.67

Strategic Growth and Productivity Program 305 61 244 2 242 (0.5) % 0.30

Non-GAAP $ 2,147 $ 502 $ 1,645 $ 64 $ 1,581 23.4 % $ 1.97

2025

Income Before

Income Taxes

Provision For Income Taxes(1)

Net Income

Including

Noncontrolling

Interests Less: Income Attributable to Noncontrolling Interests Net Income

Attributable To

Colgate-Palmolive

Company

Effective Income

Tax Rate(2)

Diluted Earnings

Per Share

As Reported GAAP $ 1,959 $ 460 $ 1,499 $ 66 $ 1,433 23.5 % $ 1.76

ERISA litigation matter 65 12 53 — 53 (0.1) % 0.06

Acquisition-related costs 9 2 7 — 7 — % 0.01

Non-GAAP $ 2,034 $ 475 $ 1,559 $ 66 $ 1,493 23.4 % $ 1.83

The impact of non-GAAP adjustments may not necessarily equal the difference between “GAAP” and “non-GAAP” as a result of rounding.

Notes:

(1) The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.

GRAPHIC

Filename: image.jpg · Sequence: 7

Binary file (59519 bytes)

Download image.jpg

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 9

v3.26.1

Cover

Jul. 31, 2026

Cover [Abstract]

Document Period End Date

Jul. 31, 2026

Document Type

8-K

Registrant Name

COLGATE-PALMOLIVE COMPANY

Entity Incorporation, State or Country Code

Entity File Number

1-644

Entity Tax Identification Number

13-1815595

Entity Address, Address Line One

300 Park Avenue,

Entity Address, City or Town

New York,

Entity Address, State or Province

Entity Address, Postal Zip Code

10022

City Area Code

(212)

Local Phone Number

310-2000

Written Communications

false

Soliciting Material

false

Pre-commencement Issuer Tender Offer

false

Class of Stock [Line Items]

Entity Emerging Growth Company

false

Pre-commencement Tender Offer

false

Central Index Key

0000021665

Amendment Flag

false

Common Stock

Cover [Abstract]

Title of 12(b) Security

Common Stock, $1.00 par value

Class of Stock [Line Items]

Title of 12(b) Security

Common Stock, $1.00 par value

Trading Symbol

Security Exchange Name

NYSE

Trading Symbol

Security Exchange Name

NYSE

0.300% Notes Due 2029

Cover [Abstract]

Title of 12(b) Security

0.300% Notes due 2029

Class of Stock [Line Items]

Title of 12(b) Security

0.300% Notes due 2029

Trading Symbol

CL29

Security Exchange Name

NYSE

Trading Symbol

CL29

Security Exchange Name

NYSE

1.375% Notes Due 2034

Cover [Abstract]

Title of 12(b) Security

1.375% Notes due 2034

Class of Stock [Line Items]

Title of 12(b) Security

1.375% Notes due 2034

Trading Symbol

CL34

Security Exchange Name

NYSE

Trading Symbol

CL34

Security Exchange Name

NYSE

3.250% Notes due 2035

Cover [Abstract]

Title of 12(b) Security

3.250% Notes due 2035

Class of Stock [Line Items]

Title of 12(b) Security

3.250% Notes due 2035

Trading Symbol

CL35

Security Exchange Name

NYSE

Trading Symbol

CL35

Security Exchange Name

NYSE

0.875% Notes due 2039

Cover [Abstract]

Title of 12(b) Security

0.875% Notes due 2039

Class of Stock [Line Items]

Title of 12(b) Security

0.875% Notes due 2039

Trading Symbol

CL39

Security Exchange Name

NYSE

Trading Symbol

CL39

Security Exchange Name

NYSE

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- References

No definition available.

+ Details

Name:

us-gaap_ClassOfStockLineItems

Namespace Prefix:

us-gaap_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Details

Name:

us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember

Namespace Prefix:

Data Type:

Balance Type:

Period Type:

- Details

Name:

us-gaap_StatementClassOfStockAxis=cl_A0.300NotesDue2029Member

Namespace Prefix:

Data Type:

Balance Type:

Period Type:

- Details

Name:

us-gaap_StatementClassOfStockAxis=cl_A1.375NotesDue2034Member

Namespace Prefix:

Data Type:

Balance Type:

Period Type:

- Details

Name:

us-gaap_StatementClassOfStockAxis=cl_A3.250NotesDue2035Member

Namespace Prefix:

Data Type:

Balance Type:

Period Type:

- Details

Name:

us-gaap_StatementClassOfStockAxis=cl_A0.875NotesDue2039Member

Namespace Prefix:

Data Type:

Balance Type:

Period Type: